Metabolon's Untargeted Metabolomics Services Used for Landmark Study Linking a Western Dietary Pattern During Pregnancy to Neurodevelopment Disorders
MORRISVILLE, N.C., May 28, 2025 /CNW/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced that Metabolon's untargeted metabolomics services were used in a landmark study led by principal investigators Rassmussen, Stokholm, Lasky-Su, and Kelly. The study, published in Nature Metabolism, revealed that blood metabolomic profiling was instrumental in uncovering biological mechanisms linking maternal diet and metabolism to neurodevelopmental disorders and in validating these associations through a consistent metabolic signature observed across multiple independent cohorts.
Globally, attention-deficit/hyperactivity disorder (ADHD) affects approximately 5–7% of children and adolescents and 2–5% of adults, with variations in prevalence influenced by regional differences in diagnostic practices. Autism spectrum disorder (ASD) has an estimated global prevalence of about 1–2% (around 1 in 100 children), although some recent studies suggest rates up to 2.3%. Boys are diagnosed with autism roughly four times more frequently than girls.
Horner et al. conducted a large-scale analysis involving over 60,000 mother-child pairs, with untargeted blood metabolomic profiling performed on a subset of approximately 1,500 pairs, featuring longitudinal maternal and child sampling, to identify metabolic dietary signatures associated with neurodevelopmental risk. Metabolon's Global Discovery Panel, an untargeted metabolomics platform, was used to generate high-resolution metabolic profiles from maternal plasma during pregnancy and from children at multiple developmental stages. Subanalyses of the child metabolomic data showed that the most pronounced associations with neurodevelopmental outcomes were linked specifically to maternal diet during pregnancy, highlighting the prenatal period as a particularly sensitive window of exposure.
The study revealed that consuming a Western diet during pregnancy significantly increased the risk of autism and ADHD in infants and children. Dietary survey data from COPSAC2010, a mother-child cohort based in Denmark, initially showed that moderate dietary shifts toward a Western dietary pattern were associated with increased ADHD risk by 66% and autism by 122%. Encouragingly, even modest improvements away from Western eating habits could meaningfully lower these risks, highlighting practical implications for prenatal nutrition. This Western dietary pattern was externally validated in the U.S.-based VDAART cohort using blood metabolomic modeling aligned with independently assessed food frequency questionnaires. Moreover, the association between this dietary pattern and ADHD risk was replicated across three independent mother-child cohorts, strengthening the inference for ADHD. Metabolomic profiling identified 15 circulating metabolites that significantly mediated the relationship between diet and neurodevelopment, offering insights into potential biological mechanisms.
"This study analyzed maternal dietary patterns during pregnancy and evaluated children's mental health at age 10. Using dietary surveys and blood metabolomics, we discovered that a Western dietary pattern in pregnancy was strongly associated with increased risk of ADHD and autism. By comparing metabolomic profiles from mid-pregnancy in the COPSAC cohort with early and late pregnancy samples from the VDAART cohort, we were able to infer that early to mid-pregnancy may represent a particularly sensitive window during which maternal diet can shape child neurodevelopment," said lead author of the study and lead COPSAC researcher Morten Arendt Rassmussen.
Co-author and Principal Investigator of the VDAART cohort Jessica Lasky-Su added, "One of the most compelling aspects of this study is that metabolomic profiling was able to identify consistent dietary signals linked to neurodevelopmental risk across cohorts that differ significantly in socioeconomic status, race, and geographic setting. These insights pave the way for targeted nutritional interventions during pregnancy that could potentially reduce the risk of neurodevelopmental disorders in children across a broad range of populations. The breadth of metabolites captured on the Metabolon platform was instrumental in enabling us to draw these conclusions."
"We're extremely pleased to support the international efforts of the COPSAC and VDAART investigative teams led by Morten Arendt Rassmussen, Jakob Stokholm, Jessica Lasky-Su, and Rachel Kelly," said Greg Michelotti, Director of Population Health at Metabolon. "This study shows the power of metabolomics and specifically Metabolon's industry-leading untargeted metabolomics services to elucidate novel insights for caregivers and parents worldwide seeking the healthiest possible outcomes for children."
Learn more about this groundbreaking scientific research here.
Learn more about Metabolon's untargeted metabolomics services here.
About Metabolon
Metabolon, Inc. is the global leader in metabolomics, with a mission to deliver biochemical data and insights that expand and accelerate the impact of life sciences research and complement other 'omics' technologies. With more than 20 years, 10,000+ projects, 3,500+ publications, and ISO 9001:2015, CLIA, and CAP certifications, Metabolon has developed industry-leading scientific, technology, and bioinformatics techniques. Metabolon's Global Discovery Panel is powered by the world's largest proprietary metabolomics reference library. Metabolon's industry-leading data and translational science expertise help customers and partners address some of the most challenging and pressing questions in the life sciences, accelerating research and enhancing development success. The company offers scalable, customizable multiomics solutions, including metabolomics and lipidomics, that support customer needs from discovery through clinical trials and product life-cycle management. For more information, please visit www.metabolon.com and follow us on LinkedIn and Twitter.
About Metabolomics
Metabolomics, the large-scale study of all small molecules in a biological system, is the only omics technology that provides a complete current-state functional readout of a biological system. Metabolomics helps researchers see beyond the genetic variation of individuals, capturing the combined impact of genetic and external factors such as the effect of drugs, diet, lifestyle, and the microbiome on human health. By measuring thousands of discrete chemical signals that form biological pathways in the body, metabolomics can reveal important biomarkers, enabling a better understanding of a drug's mechanism of action, pharmacodynamics, and safety profile, as well as individual responses to therapy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
5 hours ago
- Cision Canada
Public advisory - Risk of anaphylactic reaction associated with glatiramer acetate, used to treat multiple sclerosis Français
, /CNW/ - Summary Product: Glatiramer acetate Issue: Health products – Product safety, new safety information What to do: If you experience anaphylactic reaction symptoms, stop taking glatiramer acetate and seek immediate medical help by calling 9-1-1. Report any health product-related side effects to Health Canada. Do not restart taking glatiramer acetate unless your healthcare provider has identified another clear cause for the anaphylaxis. Affected products Issue Health Canada is warning patients that they may experience anaphylactic reactions after receiving glatiramer acetate, which is used to treat relapsing-remitting multiple sclerosis. These anaphylactic reactions can be fatal and may occur at any point during treatment, from as soon as the first dose to months or even years after starting therapy. Anaphylactic reaction symptoms generally appear within one hour of injection and may include: Sudden shortness of breath, wheezing, or difficulty breathing Swelling of the eyelids, face, lips, mouth, tongue, or throat Uncontrolled shaking Fainting or dizziness Trouble swallowing or speaking Widespread rash, hives Collapse Health Canada confirmed this new safety risk following a review of all available data, including 11 Canadian cases of anaphylactic reactions from Copaxone and three additional cases from other glatiramer acetate products. While there have been no fatal cases reported in Canada, some cases required treatment with epinephrine and other appropriate medical interventions. There have been fatal cases reported internationally. Health Canada has informed healthcare professionals, including neurologists, emergency room physicians and staff, nurses, and pharmacists about this new safety risk. The manufacturer for Copaxone has updated its Canadian product labelling to include this risk, and Health Canada is working with the manufacturers of other glatiramer acetate products — including Glatect and Mylan glatiramer acetate injection — to update their respective labelling. What you should do If you experience anaphylactic reaction symptoms, stop taking glatiramer acetate and seek immediate medical help by calling 9-1-1. Do not restart taking glatiramer acetate if you have experienced anaphylaxis unless your healthcare provider has identified another clear cause for the anaphylaxis. Report any health product-related side effects to Health Canada. What healthcare professionals should do Inform patients and/or caregivers of the signs and symptoms of anaphylactic reactions, which may overlap with those of an immediate post-injection reaction. Instruct patients to seek immediate emergency medical care in the event of an anaphylactic reaction. Instruct patients to discontinue treatment with glatiramer acetate if they have an anaphylactic reaction. Do not restart the medicine unless there is another clear reason the patient experienced an anaphylactic reaction. Également disponible en français
Cision Canada
10 hours ago
- Cision Canada
Shoppers Foundation for Women's Health commits $1.75M to support further advances in women's health equity Français
TORONTO, Aug. 21, 2025 /CNW/ - There's a crisis in women's health: only 7 per cent of national funding 1 is allocated to women's health research yet 70 per cent of patients with "medically unexplained symptoms 2" are women. The disparity in research funding and increased burden of disease for women is leading to a lack of access to high quality care – and putting women's lives at risk. Shoppers Foundation for Women's Health ™ is pleased to announce that it has invested $1.75 million through its Community Grants Program to help improve the state of women's healthcare across Canada. The work of the 27 organizations receiving grants valued up to a maximum of $100,000 this year spans the women's health landscape addressing areas including improving access to health supports for women experiencing homelessness, gender-based violence, and those in remote or rural communities, as well as initiatives focused on maternal health, menstrual equity, and mental health. "The funding delivered across Canada through our Community Grants program supports vital local charitable programs, awareness initiatives and improved access to care for women," said Paulette Minard, Director of Community Investment at Shoppers Foundation for Women's Health. "Working together with these grant recipients, Shoppers Foundation for Women's Health is committed to making care more equitable and accessible so that all women in Canada can lead healthier lives." Since 2022, the Foundation has supported 99 community-led organizations including The BC Society of Transition Houses (BCSTH) through its Community Grants Program. BCSTH supports an extensive network of member organizations that represent anti-violence workers throughout British Columbia who provide services in women's transitional housing, safe homes and PEACE counselling programs for children and youth. With a donation of $100,000 from Shoppers Foundation for Women's Health, BCSTH was able to address menstrual education and equity as well as increase support through its BCSTH Menstrual Equity Project. "We are proud to partner with Shoppers Foundation for Women's Health to address critical gaps in women's healthcare," said Amy S. FitzGerald, Executive Director at the BC Society of Transition Houses. "Violence impacts not only women's safety and health, but also creates significant financial barriers to equality and well-being. With this grant, we were able to provide menstrual products to nearly 5,000 women, many in rural, remote, and Indigenous communities. This initiative has helped ease some of the burdens faced by women and girls living with violence, and we are deeply appreciative of the continued support from Shoppers Foundation for Women's Health." The full list of recipients of this year's Community Grants program include: Access to Care Christie Refugee Welcome Centre Inc. – Toronto, ON – (Refugee Women's Wellness Program) - $14,800 Malvern Family Resource Centre – Scarborough, ON – (SHE (Support for Health & Equity) Thrives: Expanding Women's Wellness in Malvern) - $19,900 Parkdale Food Centre – Ottawa, ON – (Bridge and Bloom: Supporting Primary Care Access for Women in Ottawa) - $40,000 Alberta Northwest Palliative Care Society – Grande Prairie, AB – (Strengthening the Volunteer Program for Women: Compassion is Contagious) - $50,000 St. John's Women's Centre – St. John's, NL – (Access to Wellness Equity Project -AWEP) - $75,000 GlobalMedic – Toronto, ON – (Mobile Access to Care Program) - $75,000 Ann Davis Transition Society – Chilliwack, BC – (ADTS Mobile Outreach & Connections Project) - $98,746 Sistering-A Woman's Place – Toronto, ON – (Breaking Barriers: Equitable Healthcare for Women and Gender-Diverse People) - $99,475 Street Health Community Nursing Foundation – Toronto, ON – (Pathway to Health & Wellness Women's Drop-In) - $100,000 Vancouver Women's Health Collective Society – Vancouver, BC – (Vancouver Women's Health Collective: Expanding Capacity, and Inclusive Care in the DTES) - $100,000 S.O.S. Grossesse – Quebec City, QC – (Centre de Santé des Femmes de la Capitale-Nationale) - $100,000 Le Reflet (formerly Vide ta sacoche) – Quebec City, QC – (Mieux-être, estime et dignité pour les femmes en situation de vulnérabilité) – $100,000 Gender-Based Violence True North Society – Strathmore, AB – (Advancing Women's Equality) - $20,000 Stepping Stones Crisis Society – Cold Lake, AB – (Circle of Care: Nutrition, Connection, and Wellness for Women) - $33,500 North Shore Crisis Services Society – North Vancouver, BC – (The Welcome Program) - $35,000 Campbell River and North Island Transition Society – Campbell River, BC – (Women's Empowerment Through Better Health Program) - $58,874 Maternal Health First Steps Housing Project – Saint John, NB – (First Steps Residency Program) - $61,790 Shifra Homes Inc. – Burlington, ON – (Health Supports for Homeless Pregnant Women at Shifra Homes) - $75,000 Cape Breton Regional Hospital Foundation – Sydney, NS – (Family Newborn TLC Fund) - $80,000 The Black Women's Institute for Health – Toronto, ON – (Mothering Minds: Motherhood & Mental Health Support) - $100,000 London Health Sciences Foundation – London, ON – (Shoppers Foundation Women's Care Cupboard) - $100,000 Strongest Families Institute / L'institut des Familles Solides – Bedford, NS – (Strongest Beginnings: Equitable Perinatal Mental Health Support Without Barriers) - $100,000 Menstrual Equity Partageons l'espoir (Québec) – Montreal, QC – (FREE feminine hygiene products for all women at our food bank Initiative) - $13,380 United Way of Central Alberta Society – Red Deer, AB – (Period Promise in Central Alberta) – $20,000 Projets autochtones du Québec – Montreal, QC – (Atakaritétshera - Pour la santé et la sécurité des femmes autochtones) - $20,520 L'institut de l'innovation / Innovation Institute – Montreal, QC – (The Refugee Centre Hygiene Basket Initiative) - $60,000 BC Society of Transition Houses – Vancouver, BC – (BCSTH Menstrual Equity Project) - $100,000 Shoppers Foundation for Women's Health is a registered charity. For more information on the Foundation, please visit: About Shoppers Drug Mart Inc. Shoppers Drug Mart Inc. is one of the most recognized and trusted names in Canadian retailing. The company is the licensor of full-service retail drug stores operating under the name Shoppers Drug Mart ® (Pharmaprix ® in Québec). With more than 1,350 Shoppers Drug Mart ® and Pharmaprix ® stores operating in prime locations in each province and two territories, the company is one of the most convenient retailers in Canada. Shoppers Drug Mart ® is an independent operating division of Loblaw Companies Limited. About Shoppers Foundation for Women's Health Shoppers Foundation for Women's Health – the charitable arm of Shoppers Drug Mart ® – is committed to helping Canadian women lead healthier lives, by making care more equitable and accessible. The Foundation will invest $50M by 2026 to address some of the most pressing health inequities facing women, including lack of representation in health research, barriers to accessing mental healthcare, and the urgent consequences women disproportionately face due to poverty and domestic violence. Learn more at
Cision Canada
10 hours ago
- Cision Canada
Specsavers Canada highlights 45% of children are not receiving regular eye exams as myopia rate increases
Not so fast, myopia: Specsavers emphasizes the importance of early detection through regular eye exams as nearsightedness rates in children continue to grow TORONTO, Aug. 21, 2025 /CNW/ - Myopia (also known as nearsightedness) rates in Canadian children have steadily increased in recent years – progressing faster than in previous generations 1; however, according to a recent Specsavers Canada survey, conducted by Angus Reid Group, 82% of Canadians are unaware of this increase 2. "We're seeing a significant rise in the number of children being diagnosed with nearsightedness, more than ever before," says Naomi Barber, Clinical Services Director at Specsavers Canada. "While lifestyle changes such as spending more time outdoors and limiting screen use can help slow the progression of myopia, there is more that can be done to slow the progression and optometrists are at the frontline of this intervention. Specsavers is committed to raising awareness among parents about the importance of early detection. Making annual eye exams part of the back-to-school routine is a key step in helping to manage and control myopia in children." The Canadian Association of Optometry recommends that school-aged children receive a comprehensive eye exam every year until the age of 19. Yet, the recent national Specsavers survey revealed 45% of school-aged children in Canada are not receiving annual eye exams as recommended 2. This gap in routine eyecare is concerning, especially as rates of childhood myopia continue to rise. As part of its mission to change lives through better sight, Specsavers is encouraging parents to include a comprehensive eye exam as part of their back-to-school routine. For children diagnosed with myopia, there are specific types of glasses and contact lenses that can help slow the progression of the condition. Specsavers offers several of these solutions, with savings available during the back-to-school season. Visiting an Optometrist from a young age is important. Early intervention can help reduce children's risk of developing long-term sight-threatening conditions. Specsavers locations offer comprehensive eye exams by independent optometrists, including optical coherence tomography (OCT), a 3D advanced eye health scan that examines the back of the eye. The scan helps to assess eye health in detail and detect other causes that may be contributing to visual impairment. Children are covered for annual eye exams if they are under a provincial health care plan in most provinces. "So much of parenthood is about preparing our little ones for a bright future," adds Barber, "Whether they have their sights set on being explorers, athletes, artists, scientists or musicians, we want to make sure they're ready to do so with confidence and clear vision." Parents interested in learning more about myopia management or scheduling an eye exam for their child can visit About Specsavers Specsavers is an optometrist-owned business that entered the Canadian market in late 2021. Since then, over 158 locations have opened across the country, in B.C., Alberta, Ontario, and Manitoba. As part of Specsavers' commitment to accessible eyecare, Specsavers equips every location with optical coherence tomography (OCT) technology, which helps optometrists to detect sight-threatening conditions, such as age-related macular degeneration, glaucoma and diabetic eye disease, in their earliest stages. Founded in the UK 40 years ago by optometrist husband-and-wife team, Doug and Mary Perkins, there are now more than 2,700 Specsavers healthcare businesses globally, serving over 44 million patients and customers. Specsavers is driven by its purpose of "changing lives through better sight" and aims to transform the way Canadians experience eyecare by offering exceptional service, advanced clinical equipment and affordable and quality eyewear.
